Overview
- CMS outlined a proposed rule that would exclude hospitals from Medicare and Medicaid if they provide puberty blockers or surgical procedures to transgender minors, with the plan subject to public comment before any final action.
- The FDA issued warning letters to 12 manufacturers and sellers of chest binders marketed for pediatric gender dysphoria, noting potential enforcement actions for regulatory violations.
- NIH leadership said the agency will halt support for research related to gender transition, with the director criticizing the field.
- The ACLU announced it will challenge the measures in court, while the House passed a bill that would criminalize providers of such care to minors with penalties of up to 10 years in prison, sending the measure to the Senate.
- Major U.S. medical associations, including the AMA and AAP, maintain that gender-affirming care is a clinically appropriate standard for youth and note that surgery for children is not recommended and is rare.